RecruitingNCT04772768

Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease

Patients With Prior Coronary Artery Bypass Graft Surgery Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease

Sponsor

Amsterdam UMC, location VUmc

Enrollment

500 participants

Start Date

Aug 23, 2019

Study Type

OBSERVATIONAL

Conditions

Graft Failure Recurrent Angina After Coronary Artery Bypass Graft Coronary Artery Disease Progression

Summary

This is a multi-center, observational cohort study including patients with prior coronary artery bypass grafting (CABG) and ≥1 saphenous vein grafts (SVG) presenting with recurrent ischemic symptoms. Objective: to investigate the clinical outcomes in patients with prior CABG evaluated for bypass graft failure and progression of native coronary artery disease (CAD). Follow-up will be collected through national registry databases, electronic medical patient records and standardized telephonic assessment at 3 and 5 years follow-up.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is for people who previously had coronary artery bypass graft surgery (CABG — a heart bypass operation) and are now experiencing chest pain again. Researchers want to study whether the vein grafts used in the bypass have developed blockages and whether the original heart arteries have worsened. **You may be eligible if...** - You have had a prior CABG surgery with saphenous vein grafts (veins taken from the leg) - You are experiencing chest pain (angina) again - You are between 18 and 89 years old **You may NOT be eligible if...** - You are under 18 or 90 or older - You are in cardiogenic shock (a medical emergency where the heart can't pump enough blood) - You are pregnant - You are unwilling or unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.